ReviewPharmacology & therapeutics2022

Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences.

Kimiyasu Shiraki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.